RNA medicine enters its second act By Joachim Eeckhout, June 11, 2026 INNOVATION The COVID-19 pandemic trans- formed RNA technologies into one of the […]
Appoints Leading Oncologist Professor Susana Banerjee of The Royal Marsden as Chief Investigator CAMBRIDGE, UK and MONTREAL, CANADA, 23 April 2026 – Epitopea, a transatlantic biotech developing off-the-shelf, durable, RNA-based cancer immunotherapies, today announced that it has received […]
CAMBRIDGE, UK and MONTREAL, CANADA, 13 April 2026 — Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies […]
